A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation-Reference-Cited by-同舟云学术

A Novel Model for Prediction of Thromboembolic and Cardiovascular Events in Patients Without Atrial Fibrillation

Published:2020-09 Issue: Volume:131 Page:40-48
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Steensig Kamilla,Olesen Kevin K W^ORCID,Madsen Morten^ORCID,Thim Troels^ORCID,Jensen Lisette Okkels^ORCID,Würtz Morten^ORCID,Kristensen Steen Dalby,Bøtker Hans Erik,Lip Gregory Y H,Eikelboom John William,Maeng Michael

Funder

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Atrial fibrillation and risk of stroke: a nationwide cohort study;Christiansen;Europace,2016

2. Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease;Eikelboom;N Engl J Med,2017

3. The CHADS2 score predicts ischemic stroke in the absence of atrial fibrillation among subjects with coronary heart disease: data from the Heart and Soul Study;Welles;Am Heart J,2011

4. Comparative assessment of published atrial fibrillation stroke risk stratification schemes for predicting stroke, in a non-atrial fibrillation population: the Chin-Shan Community Cohort Study;Lip;Int J Cardiol,2013

5. Prediction of stroke or TIA in patients without atrial fibrillation using CHADS2 and CHA2DS2-VASc scores;Mitchell;Heart,2014

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Net clinical benefit of extended dual pathway inhibition according to baseline risk in patients with chronic coronary syndrome: a COMPASS substudy;European Heart Journal - Cardiovascular Pharmacotherapy;2024-03-07

2. Requirements of a Usable Scoring System for Risk Stratification in Patients With Coronary Artery Disease;Korean Circulation Journal;2024

3. The Association of CHADS-P2A2RC Risk Score With Clinical Outcomes in Patients Taking P2Y12 Inhibitor Monotherapy After 3 Months of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention;Korean Circulation Journal;2024

4. Temporal trends in characteristics and outcomes after myocardial infarction in patients with and without peripheral artery disease – A Nationwide, register-based follow-up study;International Journal of Cardiology;2024-01

5. NOAC Therapy According to CHA2DS2-VASc Without Atrial Fibrillation: A Systematic Review;Cardiology in Review;2023-07-11